Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 59

1.

Comments on: "Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan".

Salvador-Martiín S, García-González X, García MI, Blanco C, García-Alfonso P, Robles L, Grávalos C, Pachón V, Longo F, Martínez V, Sanjurjo-Sáez M, López-Fernández LA.

Pharmacol Res. 2019 May 26:104288. doi: 10.1016/j.phrs.2019.104288. [Epub ahead of print] No abstract available.

PMID:
31141714
2.

Comparison of a new rapid method for the determination of adalimumab serum levels with two established ELISA kits.

Laserna-Mendieta EJ, Salvador-Martín S, Arias-González L, Ruiz-Ponce M, Menchén LA, Sánchez C, López-Fernández LA, Lucendo AJ.

Clin Chem Lab Med. 2019 May 14. pii: /j/cclm.ahead-of-print/cclm-2019-0202/cclm-2019-0202.xml. doi: 10.1515/cclm-2019-0202. [Epub ahead of print]

PMID:
31085742
3.

ATP-Binding Cassette Transporters in the Clinical Implementation of Pharmacogenetics.

López-Fernández LA.

J Pers Med. 2018 Dec 5;8(4). pii: E40. doi: 10.3390/jpm8040040. Review.

4.

[The perspective of migrants on access to health care in the context of austerity policies in Andalusia (Spain)].

Ruiz-Azarola A, Escudero Carretero M, López-Fernández LA, Gil García E, March Cerdà JC, López Jaramillo D.

Gac Sanit. 2018 Dec 13. pii: S0213-9111(18)30241-3. doi: 10.1016/j.gaceta.2018.09.006. [Epub ahead of print] Spanish.

5.

Severe toxicity to capecitabine due to a new variant at a donor splicing site in the dihydropyrimidine dehydrogenase (DPYD) gene.

García-González X, López-Tarruella S, García MI, González-Haba E, Blanco C, Salvador-Martin S, Jerez Y, Thomas F, Jarama M, Sáez MS, Martín M, López-Fernández LA.

Cancer Manag Res. 2018 Oct 11;10:4517-4522. doi: 10.2147/CMAR.S174470. eCollection 2018.

6.

Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan.

Salvador-Martín S, García-González X, García MI, Blanco C, García-Alfonso P, Robles L, Grávalos C, Pachón V, Longo F, Martínez V, Sanjurjo-Sáez M, López-Fernández LA.

Pharmacol Res. 2018 Oct;136:133-139. doi: 10.1016/j.phrs.2018.08.026. Epub 2018 Sep 11.

PMID:
30213564
7.

Using pharmacogenetics to prevent severe adverse reactions to capecitabine.

García-González X, López-Fernández LA.

Pharmacogenomics. 2017 Aug;18(13):1199-1213. doi: 10.2217/pgs-2017-0102. Epub 2017 Jul 26. No abstract available.

PMID:
28746000
8.

Use of exome sequencing to determine the full profile of genetic variants in the fluoropyrimidine pathway in colorectal cancer patients affected by severe toxicity.

Pellicer M, García-González X, García MI, Blanco C, García-Alfonso P, Robles L, Grávalos C, Rueda D, Martínez J, Pachón V, Longo F, Martínez V, Iglesias I, Salvador S, Sanjurjo M, López-Fernández LA.

Pharmacogenomics. 2017 Aug;18(13):1215-1223. doi: 10.2217/pgs-2017-0118. Epub 2017 Jul 26.

PMID:
28745575
9.

Identification of new SNPs associated with severe toxicity to capecitabine.

Pellicer M, García-González X, García MI, Robles L, Grávalos C, García-Alfonso P, Pachón V, Longo F, Martínez V, Blanco C, Iglesias I, Sanjurjo M, López-Fernández LA.

Pharmacol Res. 2017 Jun;120:133-137. doi: 10.1016/j.phrs.2017.03.021. Epub 2017 Mar 27.

PMID:
28347776
10.

[Rethinking the Ottawa Charter 30 years later].

López-Fernández LA, Solar Hormazábal O.

Gac Sanit. 2017 Nov - Dec;31(6):443-445. doi: 10.1016/j.gaceta.2016.12.013. Epub 2017 Feb 22. Spanish. No abstract available.

11.

Cost-effectiveness of screening for DPYD polymorphisms to prevent neutropenia in cancer patients treated with fluoropyrimidines.

Cortejoso L, García-González X, García MI, García-Alfonso P, Sanjurjo M, López-Fernández LA.

Pharmacogenomics. 2016 Jun;17(9):979-84. doi: 10.2217/pgs-2016-0006. Epub 2016 Jun 1.

PMID:
27248859
12.

Gender inequalities in COPD decision-making in primary care.

Delgado A, Saletti-Cuesta L, López-Fernández LA, Gil-Garrido N, Luna Del Castillo Jde D.

Respir Med. 2016 May;114:91-6. doi: 10.1016/j.rmed.2016.03.017. Epub 2016 Mar 25.

13.

Was access to health care easy for immigrants in Spain? The perspectives of health personnel in Catalonia and Andalusia.

Vázquez ML, Vargas I, Jaramillo DL, Porthé V, López-Fernández LA, Vargas H, Bosch L, Hernández SS, Azarola AR.

Health Policy. 2016 Apr;120(4):396-405. doi: 10.1016/j.healthpol.2016.01.011. Epub 2016 Jan 18.

PMID:
26898401
14.

Clinical implementation of pharmacogenetics.

García-González X, Cabaleiro T, Herrero MJ, McLeod H, López-Fernández LA.

Drug Metab Pers Ther. 2016 Mar;31(1):9-16. doi: 10.1515/dmpt-2015-0031. Review.

15.

Ammonia Affects Astroglial Proliferation in Culture.

Bodega G, Segura B, Ciordia S, Mena Mdel C, López-Fernández LA, García MI, Trabado I, Suárez I.

PLoS One. 2015 Sep 30;10(9):e0139619. doi: 10.1371/journal.pone.0139619. eCollection 2015.

16.

Variants in CDA and ABCB1 are predictors of capecitabine-related adverse reactions in colorectal cancer.

García-González X, Cortejoso L, García MI, García-Alfonso P, Robles L, Grávalos C, González-Haba E, Marta P, Sanjurjo M, López-Fernández LA.

Oncotarget. 2015 Mar 20;6(8):6422-30.

17.

Professional Success and Gender in Family Medicine: Design of Scales and Examination of Gender Differences in Subjective and Objective Success Among Family Physicians.

Delgado A, Saletti-Cuesta L, López-Fernández LA, Toro-Cárdenas S, Luna del Castillo Jde D.

Eval Health Prof. 2016 Mar;39(1):87-99. doi: 10.1177/0163278714543686. Epub 2014 Jul 21.

PMID:
25049366
18.

Identification of genetic variants associated with capecitabine-induced hand-foot syndrome through integration of patient and cell line genomic analyses.

Wheeler HE, González-Neira A, Pita G, de la Torre-Montero JC, Alonso R, Lopez-Fernandez LA, Alba E, Martín M, Dolan ME.

Pharmacogenet Genomics. 2014 May;24(5):231-7. doi: 10.1097/FPC.0000000000000037.

19.

Quid pro quo: a mechanism for fair collaboration in networked systems.

Santos A, Fernández Anta A, López Fernández L.

PLoS One. 2013 Sep 5;8(9):e66575. doi: 10.1371/journal.pone.0066575. eCollection 2013.

20.

[Gender differences in the perception of professional achievement in family medicine, Spain].

Saletti-Cuesta L, Delgado A, Ortiz-Gómez T, López-Fernández LA.

Rev Esp Salud Publica. 2013 May-Jun;87(3):221-38. doi: 10.4321/S1135-57272013000300002. Spanish.

Supplemental Content

Loading ...
Support Center